Norboldine

Norboldine

SCHEMBL29402012

COc1cc2c(cc1O)C[C@@H]1NCCc3cc(O)c(OC)c-2c31

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 5/20 0.71
DRD2 P14416 4/20 0.71
HTR2C P28335 3/20 0.71
ALDH1A1 P00352 5/20 0.69
HPGD P15428 5/20 0.69
KDM4E B2RXH2 4/20 0.69
LMNA P02545 2/20 0.69
MAPT P10636 2/20 0.69
KMT2A Q03164 2/20 0.69
POLB P06746 1/20 0.69
HTT P42858 1/20 0.69
MCL1 Q07820 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
HSD17B10 Q99714 5/20 0.64
CHRNB2 P17787 5/20 0.61
CHRNA7 P36544 5/20 0.61
CHRNA4 P43681 5/20 0.61
CYP2D6 P10635 3/20 0.61
CYP1A2 P05177 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Norboldine SCHEMBL14367906 1.00 DRD1 (0.71) DRD1DRD2HTR2CALDH1A1HPGD
Norboldine SCHEMBL27987614 1.00 DRD1 (0.71) DRD1DRD2HTR2CALDH1A1HPGD
Norboldine SCHEMBL29886755 1.00 DRD1 (0.71) DRD1DRD2HTR2CALDH1A1HPGD
SCHEMBL30828734 0.96 DRD1 (0.70) DRD1DRD2HTR2CALDH1A1HPGD
SCHEMBL14259791 0.95 DRD1 (0.71) DRD1DRD2HTR2CALDH1A1HPGD
Laurotetanine SCHEMBL905065 0.94 DRD2 (0.74) DRD1DRD2HTR2CALDH1A1HPGD
Laurotetanine SCHEMBL31300083 0.94 DRD2 (0.74) DRD1DRD2HTR2CALDH1A1HPGD
Laurotetanine SCHEMBL905125 0.94 DRD2 (0.74) DRD1DRD2HTR2CALDH1A1HPGD
SCHEMBL14259787 0.92 ALDH1A1 (0.65) DRD1DRD2HTR2CALDH1A1HPGD
SCHEMBL11055620 0.88 ALDH1A1 (0.69) DRD1DRD2HTR2CALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114377013-B Application of norboldine and method for promoting differentiation of mesenchymal stem cells into osteoblasts 遵义医科大学附属医院 2023-12-19 CN claimed
CN-114377013-A Application of norboldine and method for promoting mesenchymal stem cells to differentiate into osteoblasts 遵义医科大学附属医院 2022-04-22 CN claimed
CN-118924753-A Medicine and application thereof in preparation of medicine for preventing or treating osteoporosis 遵义医科大学附属医院 2024-11-12 CN disclosed
CN-117723684-A Cordate houttuynia quality analysis method based on metabonomics 中山市中智药业集团有限公司 2024-03-19 CN disclosed
CN-114377013-B Application of norboldine and method for promoting differentiation of mesenchymal stem cells into osteoblasts 遵义医科大学附属医院 2023-12-19 CN disclosed
CN-114377013-B Application of norboldine and method for promoting differentiation of mesenchymal stem cells into osteoblasts 遵义医科大学附属医院 2023-12-19 CN disclosed
CN-116570628-A Clostridium northwest for treating solid tumors in humans 生物医学谷探索股份有限公司 2023-08-11 CN disclosed
CN-108911982-B Environment-friendly method for synthesizing acyloxy-substituted styrene compound 徐州博康信息化学品有限公司 2022-08-26 CN disclosed
CN-114377013-A Application of norboldine and method for promoting mesenchymal stem cells to differentiate into osteoblasts 遵义医科大学附属医院 2022-04-22 CN disclosed
CN-114377013-A Application of norboldine and method for promoting mesenchymal stem cells to differentiate into osteoblasts 遵义医科大学附属医院 2022-04-22 CN disclosed
CN-114377013-A Application of norboldine and method for promoting mesenchymal stem cells to differentiate into osteoblasts 遵义医科大学附属医院 2022-04-22 CN disclosed
CN-113197934-B Lindera aggregata leaf extract and preparation method and application thereof 浙大宁波理工学院 2022-03-11 CN disclosed